ERYTECH gives feedback on its first Investor R&D Day and provides a financial and business update for Q4 2013 Post author:admERY Post published:January 27, 2014 Post category:Newsroom ERYTECH held its first Investor R&D day and provides a financial and business update for the fourth quarter of 2013. You Might Also Like ERYTECH to Host First Quarter 2018 Conference Call and Business Update May 9, 2018 ERYTECH Provides Business and Financial Update for the First Half of 2022 September 12, 2022 ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology April 6, 2022
ERYTECH Announces Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology April 6, 2022
